333 related articles for article (PubMed ID: 1887817)
1. In vitro studies on bone resorption in neonatal mouse calvariae using a modified dissection technique giving four samples of bone from each calvaria.
Ljunggren O; Ransjö M; Lerner UH
J Bone Miner Res; 1991 Jun; 6(6):543-50. PubMed ID: 1887817
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-beta stimulates bone resorption in neonatal mouse calvariae by a prostaglandin-unrelated but cell proliferation-dependent pathway.
Lerner UH
J Bone Miner Res; 1996 Nov; 11(11):1628-39. PubMed ID: 8915770
[TBL] [Abstract][Full Text] [Related]
3. On the role of cyclic AMP as a mediator of bone resorption: gamma-interferon completely inhibits cholera toxin- and forskolin-induced but only partially inhibits parathyroid hormone-stimulated 45Ca release from mouse calvarial bones.
Lerner UH; Ransjö M; Ljunggren O; Klaushofer K; Hoffmann O; Peterlik M
J Bone Miner Res; 1991 Jun; 6(6):551-60. PubMed ID: 1653515
[TBL] [Abstract][Full Text] [Related]
4. Modifications of the mouse calvarial technique improve the responsiveness to stimulators of bone resorption.
Lerner UH
J Bone Miner Res; 1987 Oct; 2(5):375-83. PubMed ID: 3455622
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of bone resorption in vitro by serine-esterase inhibitors.
Lerner UH; Gustafson GT
Biochim Biophys Acta; 1988 Feb; 964(2):129-36. PubMed ID: 3342254
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of glucocorticoids on bone resorption in neonatal mouse calvariae stimulated by peptide and steroid-like hormones.
Conaway HH; Grigorie D; Lerner UH
J Endocrinol; 1997 Dec; 155(3):513-21. PubMed ID: 9487996
[TBL] [Abstract][Full Text] [Related]
7. Effects of cholera toxin on cyclic AMP accumulation and bone resorption in cultured mouse calvaria.
Ransjö M; Lerner UH
Biochim Biophys Acta; 1987 Oct; 930(3):378-91. PubMed ID: 2820504
[TBL] [Abstract][Full Text] [Related]
8. Stimulation of neonatal mouse calvarial bone resorption by the glucocorticoids hydrocortisone and dexamethasone.
Conaway HH; Grigorie D; Lerner UH
J Bone Miner Res; 1996 Oct; 11(10):1419-29. PubMed ID: 8889841
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factors alpha and beta can stimulate bone resorption in cultured mouse calvariae by a prostaglandin-independent mechanism.
Lerner UH; Ohlin A
J Bone Miner Res; 1993 Feb; 8(2):147-55. PubMed ID: 8442433
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous assessment of bone resorption and formation in cultures of 22-day fetal rat parietal bones: effects of parathyroid hormone and prostaglandin E2.
Vargas SJ; Raisz LG
Bone; 1990; 11(1):61-5. PubMed ID: 2331433
[TBL] [Abstract][Full Text] [Related]
11. Human cystatin C, a cysteine proteinase inhibitor, inhibits bone resorption in vitro stimulated by parathyroid hormone and parathyroid hormone-related peptide of malignancy.
Lerner UH; Grubb A
J Bone Miner Res; 1992 Apr; 7(4):433-40. PubMed ID: 1319105
[TBL] [Abstract][Full Text] [Related]
12. Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro.
Lerner UH; Larsson A
Bone; 1987; 8(3):179-89. PubMed ID: 2955802
[TBL] [Abstract][Full Text] [Related]
13. Intact insulin-like growth factor binding protein-5 (IGFBP-5) associates with bone matrix and the soluble fragments of IGFBP-5 accumulated in culture medium of neonatal mouse calvariae by parathyroid hormone and prostaglandin E2-treatment.
Hakeda Y; Kawaguchi H; Hurley M; Pilbeam CC; Abreu C; Linkhart TA; Mohan S; Kumegawa M; Raisz LG
J Cell Physiol; 1996 Feb; 166(2):370-9. PubMed ID: 8591997
[TBL] [Abstract][Full Text] [Related]
14. Cystatin C, and inhibitor of bone resorption produced by osteoblasts.
Lerner UH; Johansson L; Ranjsö M; Rosenquist JB; Reinholt FP; Grubb A
Acta Physiol Scand; 1997 Sep; 161(1):81-92. PubMed ID: 9381954
[TBL] [Abstract][Full Text] [Related]
15. A revised role for cyclic AMP in prostaglandin-induced bone resorption.
Lerner U; Gustafson GT
Med Biol; 1980 Feb; 58(1):18-24. PubMed ID: 6247586
[TBL] [Abstract][Full Text] [Related]
16. Carboxyterminal telopeptide of type I collagen, ICTP, as a marker of matrix degradation in neonatal mouse calvarial bones, in vitro.
Ljunggren O; Ljunghall S
Biosci Rep; 1992 Oct; 12(5):407-11. PubMed ID: 1290804
[TBL] [Abstract][Full Text] [Related]
17. Regulation of osteocalcin production and bone resorption by 1,25-dihydroxyvitamin D3 in mouse long bones: interaction with the bone-derived growth factors TGF-beta and IGF-I.
Staal A; Geertsma-Kleinekoort WM; Van Den Bemd GJ; Buurman CJ; Birkenhäger JC; Pols HA; Van Leeuwen JP
J Bone Miner Res; 1998 Jan; 13(1):36-43. PubMed ID: 9443788
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro.
Lerner UH; Ransjö M; Ljunggren O
Calcif Tissue Int; 1987 Jun; 40(6):323-31. PubMed ID: 2440532
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by 17 beta-estradiol of PTH stimulated resorption and prostaglandin production in cultured neonatal mouse calvariae.
Pilbeam CC; Klein-Nulend J; Raisz LG
Biochem Biophys Res Commun; 1989 Sep; 163(3):1319-24. PubMed ID: 2783137
[TBL] [Abstract][Full Text] [Related]
20. Effects of prostaglandin F2 alpha on bone formation and resorption in cultured neonatal mouse calvariae: role of prostaglandin E2 production.
Raisz LG; Alander CB; Fall PM; Simmons HA
Endocrinology; 1990 Feb; 126(2):1076-9. PubMed ID: 2298153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
